Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFECT trial of two doses of nab-paclitaxel in elderly patients with advanced breast cancer
2012-002707-18Phase 2Completed
- Sponsor
- Fondazione Sandro Pitigliani
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of paclitaxel in breast cancer (2 arms), sponsored by Fondazione Sandro Pitigliani. Primary endpoint: Event-free survival. Started Oct 2012; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-002707-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002707-18.